Anders Ask (Former)
1 – 10 of 10
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2016
- 
                        Mark
        Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
    
    - Contribution to journal › Article
 
- 2015
- 
                        Mark
        Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
    
    - Contribution to journal › Article
 
- 2011
- 
                        Mark
        Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma The ARTSCAN study
    
    - Contribution to journal › Article
 
- 2005
- 
                        Mark
        Intraoperative Radiotherapy for Patients with Carcinoma of the Pancreas.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The potential of proton beam radiation therapy in gastrointestinal cancer.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Number of patients potentially eligible for proton therapy
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        The potential of proton beam radiation therapy in head and neck cancer.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The potential of proton beam radiation for palliation and reirradiation
    
    - Contribution to journal › Article
 
- 2003
- 
                        Mark
        A systematic overview of radiation therapy effects in oesophageal cancer.
    
    - Contribution to journal › Article
 
- 1993
- 
                        Mark
        T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapy
    
    - Contribution to journal › Article
 
